Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Stress Reaction: early-phase trial registry

3 of 6 indexed Stress Reaction trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Stress Reaction: 6 US clinical trials tracked, 3 recruiting.

Stress Reaction is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Nova Southeastern University, running 1 of these trials.

Enrollment posture brief

Registry condition stress-reaction

OPEN 3 | RECR 50% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Stress Reaction (this)50%
Open-enrollment share among volume-matched conditions near Stress Reaction

Stress Reaction lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Stress Reaction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Stress Reaction is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Stress Reaction research.

    Nova Southeastern University accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Stress Reaction trials plan to enrol fewer than 100 people.

    Median target enrolment is 75 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.

  4. Stress Reaction research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Stress Reaction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Stressful experience in the ED Behavioral
1 trials
Standard social stress task Behavioral
1 trials
Self-Paced Self-Management (SPSM) Behavioral
1 trials
Bilateral alternating stimulation Behavioral
1 trials
Probiotic Dietary supplement
1 trials
Reclaiming Nature Intervention Behavioral
1 trials

US sites by state

Facility locations filed on Stress Reaction trials. A trial with sites in several states counts in each.

Washington 1 trials
South Carolina 1 trials
Oregon 1 trials
Florida 1 trials
California 1 trials
Arkansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Stress Reaction page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stress Reaction condition card totals 6 registered trials; most-linked intervention Stressful experience in the ED; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.